Health
Clinical study boosts Proteomics kidney test – The West Australian
Medical technology company, Proteomics International says a US clinical utility study on its PromarkerD predictive test for diabetic…
Medical technology innovator Proteomics says a US clinical utility study on its PromarkerD predictive test for diabetic kidney disease has shown the test to be more important to a physician who is monitoring a patients condition than the existing standard…
Continue Reading
-
Business20 hours agoBroker names 2 small cap ASX shares to buy for big returns
-
Noosa News19 hours agoMin Woo Lee, Adam Scott and Cameron Smith in the mix after Australian PGA opening round in Brisbane
-
Business19 hours agoThese top ASX 200 stocks could rise 25% to 60%
-
Business22 hours agoThis ASX All Ords stock has more than doubled investor’s money since January. Here’s why it’s tipped to surge another 45%!